Literature DB >> 7548868

[Focal and diffuse lesions in dynamic MR-mammography of healthy probands].

C K Kuhl1, C Seibert, T Sommer, B Kreft, J Gieseke, H H Schild.   

Abstract

PURPOSE: To evaluate the range of normal contrast enhancement behaviour in dynamic MR mammography of healthy breast parenchyma, and to reduce false-positive results caused by incidental contrast enhancing lesions.
MATERIALS AND METHODS: We performed a prospective two-armed study on 20 healthy premenopausal volunteers who were examined four times within one month (Group 1) or during four consecutive months (Group 2). Incidence, prevalence, morphology, and contrast enhancement pattern of lesions were evaluated.
RESULTS: 82% (9/11 of Group 1) and 78% (7/9 of Group 2) showed at least one of a total of 60 contrast enhancing lesions. In 54% or 33% (Group 1 or 2), lesions with enhancement velocity beyond the malignancy threshold were found. 72% or 75% of lesions resolved completely during follow-ups. 69% of lesions were focal with irregular border. Time/signal intensity diagrams were almost always not suspicious; no wash-out phenomenon was seen.
CONCLUSION: In MR mammography of premenopausal breast parenchyma, focal contrast enhancing lesions-even with enhancement beyond the malignancy threshold-may occur without any underlying pathology.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7548868     DOI: 10.1055/s-2007-1015977

Source DB:  PubMed          Journal:  Rofo        ISSN: 1438-9010


  2 in total

1.  Cluster analysis of signal-intensity time course in dynamic breast MRI: does unsupervised vector quantization help to evaluate small mammographic lesions?

Authors:  Gerda Leinsinger; Thomas Schlossbauer; Michael Scherr; Oliver Lange; Maximilian Reiser; Axel Wismüller
Journal:  Eur Radiol       Date:  2006-01-18       Impact factor: 5.315

2.  MR mammography in the pre-operative staging of breast cancer in patients with dense breast tissue: comparison with mammography and ultrasound.

Authors:  M Van Goethem; K Schelfout; L Dijckmans; J C Van Der Auwera; J Weyler; I Verslegers; I Biltjes; A De Schepper
Journal:  Eur Radiol       Date:  2003-11-13       Impact factor: 5.315

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.